Incyte (INCY) Prepaid Assets (2010 - 2026)
Incyte (INCY) reported Prepaid Assets of $301.3 million for Q1 2026, up 42.36% on a YoY basis from $211.7 million in Q1 2025, and down 5.2% quarter-over-quarter from $317.8 million in Q4 2025.
Incyte (INCY) Prepaid Assets (2010 - 2026) Analysis & Trends
Incyte has reported Prepaid Assets for 17 years, with the latest figure at $301.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 42.36% year-over-year to $301.3 million; the trailing twelve-month figure through Mar 2026 stood at $301.3 million (up 42.36% YoY), and the FY2025 full-year result was $317.8 million, up 88.16% from the prior year.
- Prepaid Assets for Q1 2026 stood at $301.3 million, down from $317.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $368.7 million in Q3 2025, with the low at $146.1 million in Q1 2022.
- Historically, Prepaid Assets has averaged $214.2 million across 5 years, with a median of $189.2 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 98.76% — and 2024, when it slipped 7.61%.
- Incyte's Prepaid Assets stood at $167.0 million in 2022, then grew by 9.47% to $182.8 million in 2023, then retreated by 7.61% to $168.9 million in 2024, then jumped by 88.16% to $317.8 million in 2025, then fell by 5.2% to $301.3 million in 2026.
- The last three Prepaid Assets figures came in at $301.3 million (Q1 2026), $317.8 million (Q4 2025), and $368.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301.31 Mn |
| Dec 31, 2025 | 317.83 Mn |
| Sep 30, 2025 | 368.73 Mn |
| Jun 30, 2025 | 295.65 Mn |
| Mar 31, 2025 | 211.65 Mn |
| Dec 31, 2024 | 168.91 Mn |
| Sep 30, 2024 | 205.13 Mn |
| Jun 30, 2024 | 207.96 Mn |
| Mar 31, 2024 | 189.24 Mn |
| Dec 31, 2023 | 182.83 Mn |
| Sep 30, 2023 | 171.75 Mn |
| Jun 30, 2023 | 167.14 Mn |
| Mar 31, 2023 | 194.26 Mn |
| Dec 31, 2022 | 167.01 Mn |
| Sep 30, 2022 | 179.93 Mn |
| Jun 30, 2022 | 165.95 Mn |
| Mar 31, 2022 | 146.13 Mn |
| Dec 31, 2021 | 126.28 Mn |
| Sep 30, 2021 | 101.73 Mn |
| Jun 30, 2021 | 84.25 Mn |